Gregor Jezernik

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Rheumatoid Arthritis

Top Venues

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mario Gorenjak, Boris Gole, Larisa Goričan, Gregor Jezernik, Uršula Prosenc Zmrzljak, Cvetka Pernat, Pavel Skok, Uroš Potočnik
Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn's Disease. Pharmaceutics 16 (6) (2024)
Mario Gorenjak, Boris Gole, Larisa Goričan, Gregor Jezernik, Uršula Prosenc Zmrzljak, Cvetka Pernat, Pavel Skok, Uroš Potočnik
Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn's Disease. Pharmaceutics 16 (6) (2024)
Gregor Jezernik, Mario Gorenjak, Uroš Potočnik
MIF Variant rs755622 Is Associated with Severe Crohn's Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes 14 (2) (2023)
Martina Krušič, Gregor Jezernik, Uroš Potočnik
Gene Ontology Analysis Highlights Biological Processes Influencing Responsiveness to Biological Therapy in Psoriasis. Pharmaceutics 15 (8) (2023)
Gregor Jezernik, Mario Gorenjak, Uroš Potočnik
MIF Variant rs755622 Is Associated with Severe Crohn's Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes 14 (2) (2023)
Gregor Jezernik, Mario Gorenjak, Uroš Potočnik
MIF Variant rs755622 Is Associated with Severe Crohn's Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes 14 (2) (2023)
Gregor Jezernik, Mario Gorenjak, Uroš Potočnik
Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis. Biomedicines 10 (8) (2022)
Staša Jurgec, Gregor Jezernik, Mario Gorenjak, Tomaž Büdefeld, Uroš Potočnik
Meta-Analytic Comparison of Global RNA Transcriptomes of Acute and Chronic Myeloid Leukemia Cells Reveals Novel Gene Candidates Governing Myeloid Malignancies. Cancers 14 (19) (2022)
Mario Gorenjak, Gregor Jezernik, Martina Krušič, Pavel Skok, Uroš Potočnik
Identification of Novel Loci Involved in Adalimumab Response in Crohn's Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue. Pharmaceutics 14 (9) (2022)
Damjan Glavač, Miranda Mladinić, Jelena Ban, Graciela L Mazzone, Cynthia Sámano, Ivana Tomljanović, Gregor Jezernik, Metka Ravnik-Glavač
The Potential Connection between Molecular Changes and Biomarkers Related to ALS and the Development and Regeneration of CNS. International journal of molecular sciences 23 (19) (2022)
Kristijan Skok, Lidija Gradišnik, Helena Čelešnik, Marko Milojević, Uroš Potočnik, Gregor Jezernik, Mario Gorenjak, Monika Sobocan, Iztok Takač, Rajko Kavalar, Uroš Maver
MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines. Cells 11 (1) (2021)
Gregor Jezernik, Dušanka Mičetić-Turk, Uroš Potočnik
Molecular Genetic Architecture of Monogenic Pediatric IBD Differs from Complex Pediatric and Adult IBD. Journal of personalized medicine 10 (4) (2020)